Search Tag: European Medicines Agency
2020 09 Apr
An early-released review warns about potentially serious adverse events for chloroquine, hydroxychloroquine and azithromycin when used to treat and prevent COVID-19 . It comes only days after the U.S. Centers for Disease Control and Prevention (CDC) had removed guidelines for using hydroxychloroquine as a potential treatment. ...Read more
2020 03 Apr
The European Medicines Agency has warned against widespread use of the drug chloroquine to treat COVID-19 . You may also like: COVID-19: From Hydroxychloroquine to Plasma Administration An unproven medicine against COVID-19, chloroquine and the less toxic hydroxychloroquine are currently licensed to treat malaria...Read more
2020 31 Jan
Innovative cancer drugs take longer to pass through clinical trials, licensing and appraisal for availability on the National Health Service ( NHS) than more conventional treatments, shows a recent study published in Drug Discovery Today . You may also like: Cancer Research UK: Delays That Could Have Been Avoided In...Read more
2015 04 Jul
The European Medicines Agency (EMA) has recommended the introduction of more effective educational material to promote appropriate use of adrenaline auto-injectors. The move came following concerns that currently available devices may deliver adrenaline under the skin instead of into a muscle, hence delaying response to treatment. Adrenaline auto-injectors...Read more
2014 17 Nov
EMA supports innovative approaches to facilitate development of new antibiotics The European Medicines Agency (EMA) supports European Antibiotic Awareness Day (EAAD), which is taking place on Tuesday 18 November. EAAD is organised every year by the European Centre for Disease Prevention and Control (ECDC). It aims to raise awareness of the threat...Read more